POWERING THE UK’S APPROACH TO ANTIMICROBIAL RESISTANCE

  19 September 2020

Antimicrobial Resistance (AMR) is one of the defining challenges of our time. An increasing number of infections caused by bacteria, fungi, parasites and viruses are becoming resistant to antimicrobial drugs and antibiotics, threatening to turn routine procedures and treatments like c-sections and chemotherapy into life-critical endeavours.

The  UK has been at the forefront of efforts to battle AMR, recently publishing its 2040 Vision for tackling AMR and 5-year national action plan, and announcing a novel reimbursement model to accelerate investment in antibiotic development. Achieving sustained transformation, however, requires action across several fronts and ongoing cooperation with governments and industry alike. With the COVID-19 pandemic radically reshaping the world and testing the resilience of healthcare systems worldwide, it is crucial not to lose sight of the silent pandemic that is AMR.

Further reading: Reform
Author(s): Reform
Effective Surveillance  
Back


Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!